Application 218364
- Type
- ANDA
- Sponsor
- MYLAN LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 500MG/100ML (5MG/ML) | No | No |
| 002 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1GM/100ML (10MG/ML) | No | No |
| 003 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1.5GM/100ML (15MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | |
| A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | |
| A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218364-001 | AP |
| A218364-002 | AP |
| A218364-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218364-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218364-002 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218364-003 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218364-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218364-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218364-003 | AP | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-002 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-003 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM | Solco Healthcare US, LLC | 57f09129-7151-4a75-9d73-9dd32f74ba43 | 2024-03-27 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Solco Healthcare US, LLC | dd713e60-478c-43cd-b680-ff594a0b3864 | 2024-03-27 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | PAI Holdings, LLC dba PAI Pharma | 9dca1330-52ca-47a4-a134-ec55c9d5786d | 2024-03-27 | Warnings, Adverse reactions | LEVETIRACETAM |
| ELEPSIA XR 1000 MG | LEVETIRACETAM | TRIPOINT THERAPEUTICS, LLC | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 2024-03-25 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Gland Pharma Limited | aa883d9c-c6cd-44ab-a1de-058985e4f97f | 2024-03-25 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Mylan Institutional LLC | 70e52e89-3844-4cd9-a406-b29e9520a12c | 2024-03-15 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Proficient Rx LP | 6bdbc193-d86b-4bd5-8e88-4ea964d2cdde | 2024-03-01 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Patrin Pharma, Inc. | 49117cee-a96c-4593-91a7-8a133e3f0939 | 2024-02-15 | Warnings, Adverse reactions | LEVETIRACETAM |
| levetiracetam | LEVETIRACETAM | MAJOR PHARMACEUTICALS | 6913c611-4994-4501-8ed9-45161f90373e | 2023-12-28 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | WG Critical Care, LLC | 5e5b0ed3-b104-45a7-bb3e-ee56febb46e8 | 2023-10-30 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Natco Pharma USA LLC | 34af3602-0188-4d2e-904b-2e40000bb45c | 2023-08-05 | Warnings, Adverse reactions | LEVETIRACETAM |
| LEVETIRACETAM | LEVETIRACETAM | Armas Pharmaceuticals Inc. | 7be45c40-8d75-4c40-97a4-95067129bc2a | 2023-07-24 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam ER | LEVETIRACETAM | Proficient Rx LP | a0ad8200-70c9-4f4f-86c5-4a8c6c9f0223 | 2022-12-01 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam ER | LEVETIRACETAM | Proficient Rx LP | 57b9dccb-6ee6-4e89-ab26-4c478e2df2b5 | 2022-04-01 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Fresenius Kabi USA, LLC | cc4a06f1-6509-4650-b20c-259a39353733 | 2022-02-28 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Fresenius Kabi USA, LLC | cc41696c-9cf0-4410-bacc-09132ee805ce | 2022-01-24 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Prinston Pharmaceutical Inc. | d818ef84-9b3e-434b-92d9-910cfa8af7da | 2020-08-01 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Dr. Reddy's Laboratories Limited | 1f3c04d9-cccb-06a3-a0f3-f7c9228ee743 | 2018-12-05 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Dr. Reddy's Laboratories Limited | ee03507b-cb35-4fe9-ae7b-85ea89f876f0 | 2018-12-05 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Exelan Pharmaceuticals, Inc. | 28c0e61e-1af9-410a-9fa9-b71bf99a776b | 2018-11-29 | Warnings, Adverse reactions | LEVETIRACETAM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.